UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
May 16, 2019 (May 15, 2019)
MJ BIOTECH, INC
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
|
|
|
|
Wyoming
|
|
000-54616
|
|
45-2282672
|
(State or other jurisdiction of
incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
4781 North Congress Avenue, Suite 1102
Boynton Beach, Florida 33426
(Address of principal executive offices, including zip code)
(561) 523-3830
(Registrant ’ s telephone number, including area code)
(Former name or former address, if changed since last report)
109 East 17
th
Street, Suite 80
Cheyenne, Wyoming
82001
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01
Other Events.
Effective immediately, the Company’s principal office have moved from:
109 East 17
th
Street, Suite 80
Cheyenne, Wyoming
82001
To:
4781 North Congress Avenue, Suite 1102
Boynton Beach, Florida 33426
The contact telephone number remains unchanged.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
MJ BIOTECH, INC
|
|
|
|
|
Dated May 16, 2019
|
By:
|
/s/ Maxine Pierson
|
|
Maxine Pierson
|
|
|
Chief Executive Officer
|